Țară: Australia
Limbă: engleză
Sursă: Department of Health (Therapeutic Goods Administration)
Amoxycillin trihydrate; Potassium clavulanate; Amoxycillin (as trihydrate)
Actavis Pty Ltd
Medicine Registered
GA-AMCLAV 125/31.25 SYRUP 1 GA-AMCLAV 125/31.25 SYRUP _Amoxycillin (as trihydrate) and Clavulanic Acid (as potassium clavulanate) _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? Please read this leaflet carefully before you give GA-Amclav 125/31.25 syrup. This leaflet answers some common questions about GA-Amclav 125/31.25 syrup. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Sometimes new risks are found even when a medicine has been used for many years. Your doctor has weighed the expected benefits of your child taking GA- Amclav 125/31.25 syrup against the risks this medicine could have for your child. GA-Amclav 125/31.25 must be given to your child as instructed. If you have any concerns about giving this medicine to your child, ask your doctor or pharmacist. Keep this leaflet until your child has finished the course of GA-Amclav 125/31.25 syrup. You may need to read it again. WHAT IS GA-AMCLAV 125/31.25 SYRUP USED FOR? GA-Amclav 125/31.25 syrup contains two active ingredients. One of these is a penicillin called amoxycillin and the other is clavulanate. GA-Amclav 125/31.25 syrup belongs to the penicillin group of antibiotics. GA-Amclav 125/31.25 syrup is used to treat a wide range of infections caused by bacteria. These infections may affect the chest (bronchitis or pneumonia), bladder (cystitis), sinuses (sinusitis), the ears (otitis media) or the skin. GA-Amclav 125/31.25 syrup works by killing the bacteria that cause these infections. GA-Amclav 125/31.25 syrup is used for the treatment of the infections listed. However the doctor may prescribe this medicine for Citiți documentul complet
1 GA-AMCLAV 125/31.25 PRODUCT INFORMATION (AMOXYCILLIN TRIHYDRATE AND POTASSIUM CLAVULANATE) NAME OF THE MEDICINE GA-AMCLAV 125/31.25 is a combination product containing the semisynthetic antibiotic amoxycillin and the β-lactamase inhibitor, potassium clavulanate (the potassium salt of clavulanic acid). Chemically, amoxycillin is D-(-)- α-amino-p-hydroxybenzyl-penicillin trihydrate. It is susceptible to hydrolysis by β- lactamases. (Chemical formula: C 16 H 19 N 3 O 5 S,3H 2 O ; Molecular weight: 419.4 ; CAS – 61336-70-7) Clavulanic acid is produced by the fermentation of _Streptomyces clavuligerus_. It is an irreversible inhibitor of many β-lactamase enzymes except type 1 (Richmond). It is a β-lactam compound with only weak antibacterial activity. Chemically potassium clavulanate is potassium Z-(2R,5R)-3-(B-hydroxyethylidene) clavam-2-carboxylate. (Chemical formula: C 8 H 8 KNO 5 Amoxycillin clavulanic acid is stable in the presence of gastric acid. Its two components are rapidly absorbed if administered before or with a meal, but if given after meals, the serum levels of clavulanic acid are significantly reduced. In fasting subjects mean peak serum levels after 1 Amoxycillin clavulanic acid tablet 250mg/125mg were 2.98 mg/L (range 1.2 to 5.1 ) for clavulanic acid and 3.89 mg/L (range 2.4 to 6.0 ) for amoxycillin. These levels occurred at 30 to 120 minutes and 60 to 240 minutes respectively after dosing. Following 1 amoxycillin clauvalnic acid 500mg/125mg tablet peak serum levels in fasting subjects were ; Molecular weight: 237.3 ; CAS – 61177-45-5) DESCRIPTION GA-AMCLAV 125/31.25 also contains the inactive ingredients xanthum gum, aspartame, silicon dioxide, silica colloidal anhydrous, succinic acid, hypromellose and Artificial M Citiți documentul complet